Pediatric Obesity Co-Morbidities: Type 2 Diabetes – Prevention, Assessment, and Treatment
- Review prevalence, risk factors, and pathophysiology of Type 2 Diabetes Mellitus in children.
- Discuss screening for and diagnosis of Type 2 Diabetes in children.
- Explore treatment options for pre-diabetes and Type 2 Diabetes in children.
Professional Practice Gap
Treating pediatric patients with obesity is not something that was taught in medical school when many pediatricians and family medicine physicians were trained. There has been an increase in the number of Type 2 Diabetic pediatric patients during the past few years. It is important that members of the healthcare team have the knowledge and skills to treat pediatric patients that have obesity and Type 2 diabetes.
Relevant to the content of this educational activity, the planning committee members and speaker indicated they have no financial relationships with commercial interests to disclose.
Vanessa Curtis, MD
Associate Program Director, Pediatric Endocrinology Fellowship, University of Iowa Carver College of Medicine
Clinical Associate Professor of Pediatrics - Endocrinology and Diabetes, University of Iowa Carver College of Medicine
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the Iowa Medical Society Foundation. DMU is accredited by the IMS to provide continuing medical education for physicians. DMU designates this live, on-line activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit awarded.
- Other Health Professionals: This live activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
No commercial interest company provided financial support for this continuing education activity.
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 1.00 AMA PRA Category 1 Credits™
- 1.00 AOA Category 2A
- 1.00 CE Contact Hour(s)
- 1.00 IBON